Publications of Udo Reichl

Pelz, L., Rüdiger, D., Dogra, T., Alnaji, F. D., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U.Semi-continuous Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing the Dynamic Competition To Select Candidates for Antiviral TherapyPresented at: Vir-AI-DIP WorkshopHamburg (Germany), July 18, 2023.

Rexer, T., Hoang Son, T., Alcalá Orozco, E. A., Juárez-Osorio, M., Kleeberg, S., & Reichl, U.Activated sugar for oligosaccharides synthesisPresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Rüdiger, D., Küchler, J., Piasecka, J., Pontes, C., Kupke, S. Y., & Reichl, U.OP7, a defective interfering particle with mutations: in vitro infection experiments, intracellular model, impact of mutations and mode of antiviral actionPresented at: 6^th Workshop on Virus DynamicsNagoya (japan), July 4, 2023.

Rüdiger, D., Pelz, L., Hein, M. D., Kupke, S. Y., & Reichl, U.Multiscale model of influenza A virus and defective interfering particle co-infection in animal cell culturePresented at: Vir-AI-DIP WorkshopHamburg (Germany), July 18, 2023.

Wenzel, L., Rexer, T., & Reichl, U.Synthesis of Synthetic Lipid-Linked Oligosaccharides for In-Vitro Glycoengineering of Hemagglutinin Peptides by a Cell-Free, Multi-Enzyme CascadePresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Wenzel, L., Ruhnau, J., Rexer, T., & Reichl, U.Chemoenzymatic glycosylation of polypeptides using eukaryotic oligosaccharyltransferase and synthetic lipid-linked glycansPresented at: Glyco26Taipei (Taiwan), August 27, 2023.

Zinnecker, T. M., Badri, N., Araujo, D., Hinkelmann, A., Thiele, K., Reichl, U., & Genzel, Y.Novel approach towards vaccine manufacturing: from single-cell cloning to high-yielding influenza virus productionPresented at: 4^th Global Bioprocessing, Bioanalytics and ATMP Manufacturing CongressDublin (Ireland), May 15, 2023.

Zinnecker, T. M., Badri, N., Araujo, D., Hinkelmann, A., Thiele, K., Reichl, U., & Genzel, Y.A quest for the best influenza producing clonal MDCK cell line: intensifying by design of experiments, ambr15 and bench-top bioreactor cultivationsPresented at: World Biopharm Forum 2023 - Democratisation of biotherapies: new manufacturing modalities and intensificationsOxford (United Kingdom), June 21, 2023.

Zuniga-Banuelos, F. J., Hoffmann, M., Budimir, I., Reichl, U., & Rapp, E.New avenues for biomarker discovery in human blood plasma via an improved in-depth analysis of the low-abundant N-glycoproteomePresented at: GlycoBioTec 2023Berlin, Germany, January 17, 2023.

Göbel, S., Pelz, L., Behrendt, I., Prömmel, M., Altomonte, J., Anderlei, T., Bürgin, T., Genzel, Y., & Reichl, U.Scale-Down of an Ortbital Shaken Bioreactor: High Cell Density Cultivation in Perfusion Mode and Virus productionPresented at: Single-Use Technologies V: Building the FutureMarseille, France, March 20, 2022.

Gränicher, G., Göbel, S., Marichal-Gallardo, P., Jordan, I., Sandig, V., Genzel, Y., & Reichl, U.Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapyPresented at: Value through intensified bioprocessing IIOxford, United Kingdom, June 22, 2022.

Gränicher, G., Göbel, S., Marichal-Gallardo, P., Jordan, I., Sandig, V., Genzel, Y., & Reichl, U.Integrated cell-culture based MVA virus production process with perfusion mode for vaccines or gene therapyPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Hein, M., Chawla, A., Arora , P., Cattaneo, M., Winkler, M., Pöhlmann, S., Schughart, K., Genzel, Y., Kupke, S. Y., & Reichl, U.Production of influenza A virus defective interfering particles in a high cell density perfusion cultivation with continuous virus harvestingPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.

Hein, M., Dogra, T., Arora , P., Rand , U., Genzel, Y., Cattaneo, M., Winkler, M., Cicin-Sain, L., Bruder, D., Schughart, K., Pöhlmann, S., Kupke, S. Y., & Reichl, U.Influenza A Virus-Derived Defective Interfering Particles for Antiviral TreatmentPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.

Juárez-Osorio, M., Darr, A., Volckmar, J., Bruder, D., Rexer, T., & Reichl, U.Towards full control over protein glycosylation: In-vitro glycoengineering of Influenza A virus Hemagglutinin and SARS-CoV-2 spike proteinPresented at: 32^nd Joint Glycobiology MeetingUtrecht (The Netherlands), September 18, 2022.

Khesali Aghtaei, H., Benndorf, D., & Reichl, U.Biological methanation using a tubular foam bioreactorPresented at: Smart Process Systems Engineering 2022 Towards Sustainable & Circular Production Processes (SmartProSys 2022)Magdeburg, Germany, March 2, 2022.

Khesali Aghtaei, H., Benndorf, D., Sczyrba, A., & Reichl, U.Adaptation of a methanogenic community to demand-oriented biological methanationPresented at: 4th International Metaproteomics SymposiumLuxembourg, Luxembourg, September 27, 2021.

Kupke, S. Y., Hein, M. D., Bdeir, N., Rand, U., Marichal-Gallardo, P., Cicin-Sain, L., Bruder, D., Pöhlmann, S., Schughart, K., & Reichl, U.Influenza A Virus Defective Interfering Particles for Antiviral Treatment of the Influenza Disease and COVID-19Presented at: 31st Annual Meeting of the Society for Virologyonline, March 30, 2022.

Pelz, L., Rüdiger, D., Dogra, T., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U.Long-Term Propagation of Influenza A Virus and Its Defective Interfering Particles: Analyzing Dynamic Competition to Select Antiviral CandidatesPresented at: Vaccine Technology VIIISitges (Spain), June 12, 2022.

Pelz, L., Rüdiger, D., Dogra, T., Alnaji, F. G., Genzel, Y., Brooke, C. B., Kupke, S. Y., & Reichl, U.Semi-Continuous propagation of Influenza A virus and its defective interfering particles: Analyzing the dynamic competition to select antiviral candidatesPresented at: 27th ESACT MeetingLisbon (Portugal), June 26, 2022.